Picard Medical, Inc.
Cash Flow Statement
| Line Item | FY2025 | FY2024 |
|---|---|---|
| Operating Activities | ||
| Net Income | $-27.0M | $-21.1M |
| Depreciation & Amortization | $163.0K | $226.0K |
| Depreciation | $76.0K | $27.0K |
| Amortization | $87.0K | — |
| Stock-Based Compensation | $754.0K | $886.0K |
| Net Cash from Operating Activities | $-15.7M | $-11.9M |
| Investing Activities | ||
| Capital Expenditures | — | — |
| Business Acquisitions | — | — |
| Net Cash from Investing Activities | — | $0 |
| Financing Activities | ||
| Dividends Paid | — | — |
| Stock Repurchases | — | — |
| Net Cash from Financing Activities | $27.1M | $11.7M |
| Net Change in Cash | $11.4M | $-148.0K |
| Free Cash Flow | — | — |